e-Drug3D 1487 |
cas 199739-10-1 |
CLASS NERVOUS SYSTEM |
ROUTE (list) INTRAMUSCULAR |
ATC code |
PK parameters Solubility VERY SLIGHTLY SOLUBLE IN ETHANOL |
Target TARGET 5-HYDROXYTRYPTAMINE 2A RECEPTOR |
DrugCentral D(2) dopamine receptor UNIPROT P14416 DRD2 5-hydroxytryptamine receptor 2A UNIPROT P28223 HTR2A |
Download SDF file | Hexadecanoic acid, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl ester Formula: Calculated chemical properties: MW 664.89 NB_atoms 48 XLogP 9.11 PSA 83.131 NB_HD 0 NB_HA 8 fsp3 0.69 Lipinski(0=no;1=yes) 0 |
FDA NDA 022264 (pdf not found) INN (PALIPERIDONE PALMITATE) INVEGA SUSTENNA (JANSSEN PHARMS) APPROVAL= AP YEAR= 2009 NDA 207946 (pdf not found) INN (PALIPERIDONE PALMITATE) INVEGA TRINZA (JANSSEN PHARMS) APPROVAL= AP YEAR= 2015 NDA 211149 (pdf not found) INN (PALIPERIDONE PALMITATE) PALIPERIDONE PALMITATE (TEVA PHARMS USA) APPROVAL= AP YEAR= 2021 NDA 211995 (pdf not found) INN (PALIPERIDONE PALMITATE) PALIPERIDONE PALMITATE (TOLMAR) APPROVAL= TA YEAR= 2023 NDA 210397 (pdf not found) INN (PALIPERIDONE PALMITATE) PALIPERIDONE PALMITATE (PHARMASCIENCE INC) APPROVAL= TA YEAR= 2024 NDA 216228 (pdf not found) INN (PALIPERIDONE PALMITATE) PALIPERIDONE PALMITATE (MYLAN PHARMS INC) APPROVAL= TA YEAR= 2024 NDA 215682 (pdf not found) INN (PALIPERIDONE PALMITATE) PALIPERIDONE PALMITATE (MYLAN PHARMACEUTICALS INC A VIATRIS CO) APPROVAL= TA YEAR= 2024 NDA 216352 (pdf not found) INN (PALIPERIDONE PALMITATE) ERZOFRI (LUYE INNOMIND PHARMA) APPROVAL= AP YEAR= 2024 NDA 216674 (pdf not found) INN (PALIPERIDONE PALMITATE) PALIPERIDONE PALMITATE (ACCORD HLTHCARE INC) APPROVAL= TA YEAR= 2025 |
Other links: |